Table 1 The key data of all studies targeting the dopamine transporter
Year | First author | Tracer (target) | Method | TS patients | Healthy controls | Scores | Drug free |
|---|---|---|---|---|---|---|---|
2000 | Müller-Vahl | ß-CIT (DAT) | SPECT | 6 | 9 | STSS 3,3 (6) | 5 month |
2001 | Stamenkovic | ß-CIT (DAT) | SPECT | 15 | 10 | YGTTS 67,65 (100) | Drug-naïve |
2004 | Serra-Mestres | FP-CIT (DAT) | SPECT | 10 | 10 | YGTTSS 47,6 (100) | Drug-naïve |
2007 | Yeh | TRODAT (DAT) | SPECT | 8 | 8 | YGTTSS 25 (100) | Drug-naïve |
2008 | Hwang | TRODAT (DAT) | SPECT | 10 | 15 | MRVRS 11,7 (20) | 3 month |
2008 | Wong | C11 WIN (DAT) | PET | 11 | 5 | YGTSS 50,27 (100) | 6 month |
2009 | Albin | MP (DAT) | PET | 33 | 28 | YGTSS 37 (100) | 3 month |
2010 | Liu | TRODAT (DAT) | SPECT | 18 | 8 | YGTTSS 39,17 (100) | Drug naive |
SUM | 111 | 93 |
